Variations in the expression of inhibitory T cell receptors (PD-1 and 2B4) on CD8+ T lymphocytes have been linked to the immune tolerance necessary for the MASH progression [74]. Here, PDCD1 is linked to metabolic dysfunction-associated steatohepatitis.